Alland Leila Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$51,799.00
Insider Sells Quantity
9
Insider Sells Sum
$1.16M

Insider Activity of Alland Leila

According to the SEC Form 4 filings, Alland Leila, being in a position of

  1. director at Abeona Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 29065 shares for $157,049,
    over all time since 2023-09-27, has bought 11000 shares for $51,799, and sold 36311 share for $185,318.

Biography of Alland Leila

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$157,0492100

Comparison of Insiders on Amount of Buys and Sells

2026-06-30SaleAbeona Therapeutics Inc.
ABEO
director
11,000
0.0185%
$5.92$65,087-3.96%
2026-02-02SaleAbeona Therapeutics Inc.
ABEO
director
18,065
0.0328%
$5.09$91,962+5.32%
2024-05-16PurchaseAbeona Therapeutics Inc.
ABEO
director
11,000
0.0286%
$4.71$51,799+18.59%
2023-09-27SaleAbeona Therapeutics Inc.
ABEO
director
7,246
0.0288%
$3.90$28,270+21.97%
2023-09-15SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
6,291
0.0128%
$6.62$41,646-74.14%
2021-09-09SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
100
0.0002%
$30.25$3,025-40.96%
2021-09-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
3,900
0.009%
$30.25$117,975-40.85%
2021-08-09SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,471
0.0095%
$34.04$152,202-46.87%
2021-07-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,000
0.0088%
$32.30$129,213-32.29%
2021-06-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,000
0.0089%
$33.60$134,387-30.42%
2021-05-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
8,000
0.0177%
$34.83$278,618-30.86%
2021-04-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
8,000
0.0178%
$33.86$270,889-19.47%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.